Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|---|---|---|---|---|---|---|---|
NPO1356 | Bacillus circulans | Species | Bacillaceae | Bacteria | UNPD* | |||
NPO8565 | Dioscorea dumetorum | Species | Dioscoreaceae | Eukaryota | UNPD* | |||
NPO2867 | Cotula coronopifolia | Species | Asteraceae | Eukaryota | UNPD* | |||
NPO8281 | Epimedium davidi | Species | Berberidaceae | Eukaryota | UNPD* | |||
NPO7567 | Parmelia rigida | Species | Parmeliaceae | Eukaryota | UNPD* | |||
NPO10244 | Aglaia elliptifolia | Species | Meliaceae | Eukaryota |
PMID[9214732] |
|||
NPO32616 | aglaia sp. | Species | Meliaceae | Eukaryota |
PMID[10775404] |
|||
NPO10244 | Aglaia elliptifolia | Species | Meliaceae | Eukaryota | Root | DOI[10.1039/C39820001150] | ||
NPO10244 | Aglaia elliptifolia | Species | Meliaceae | Eukaryota | Stems | DOI[10.1039/C39820001150] | ||
NPO27686 | Aglaia odorata | Species | Meliaceae | Eukaryota | Leaves | DOI[10.1016/S0031-9422(00)94986-0] | ||
NPO28468 | Aglaia duperreana | Species | Meliaceae | Eukaryota | Root | DOI[10.1021/np990242g] | ||
NPO8409 | Galium semiamictum | Species | Rubiaceae | Eukaryota | UNPD* | |||
NPO13865 | Cucumaria chronhjelmi | Species | Cucumariidae | Eukaryota | UNPD* | |||
NPO1360 | Penicillium nordicum | Species | Aspergillaceae | Eukaryota | UNPD* | |||
NPO15626 | Alternaria japonica | Species | Pleosporaceae | Eukaryota | UNPD* | |||
NPO4528 | Penicillium lapatayae | Species | Aspergillaceae | Eukaryota | UNPD* |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2 | Others | Unspecified | IC50 | = | 2000 | nM | 17055270 | |
NPT2 | Others | Unspecified | Activity | = | 77.6 | % | 9214732 | |
NPT2 | Others | Unspecified | Activity | = | 90.5 | % | 9214732 | |
NPT2 | Others | Unspecified | Activity | = | 85.5 | % | 9214732 | |
NPT2 | Others | Unspecified | Activity | = | 83.8 | % | 9214732 | |
NPT91 | Cell Line | KB | Homo sapiens | IC50 | = | 0.006 | ug/ml | 9214732 |
NPT81 | Cell Line | A549 | Homo sapiens | IC50 | = | 0.006 | ug/ml | 9214732 |
NPT180 | Cell Line | HCT-8 | Homo sapiens | IC50 | = | 0.007 | ug/ml | 9214732 |
NPT168 | Cell Line | P388 | Mus musculus | IC50 | = | 0.005 | ug/ml | 9214732 |
NPT1091 | Cell Line | RPMI-7951 | Homo sapiens | IC50 | = | 0.002 | ug/ml | 9214732 |
NPT672 | Cell Line | TE-671 | Homo sapiens | IC50 | = | 0.006 | ug/ml | 9214732 |
NPT721 | Individual Protein | Nuclear factor NF-kappa-B p65 subunit | Homo sapiens | IC50 | = | 80 | nM | 19839614 |
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | IC50 | = | 2000 | nM | 19839614 |
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | ED50 | = | 0.002 | nM | 19422206 |
NPT721 | Individual Protein | Nuclear factor NF-kappa-B p65 subunit | Homo sapiens | IC50 | = | 4000 | nM | 20384315 |
NPT163 | Individual Protein | Nuclear factor NF-kappa-B p105 subunit | Homo sapiens | IC50 | = | 75 | nM | 20384315 |
NPT2 | Others | Unspecified | Potency | 51.7 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 20.6 | nM | PubChem BioAssay data set | |
NPT721 | Individual Protein | Nuclear factor NF-kappa-B p65 subunit | Homo sapiens | IC50 | = | 75 | nM | 21428375 |
NPT721 | Individual Protein | Nuclear factor NF-kappa-B p65 subunit | Homo sapiens | IC50 | = | 75 | nM | 21513293 |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 125.9 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 112.2 | nM | PubChem BioAssay data set | ||
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 3.548 | nM | PubChem BioAssay data set | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 8.147 | nM | PubChem BioAssay data set | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 8.851 | nM | PubChem BioAssay data set | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 3.436 | nM | PubChem BioAssay data set | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 15.85 | nM | PubChem BioAssay data set | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 13.77 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 3.828 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 8.091 | nM | PubChem BioAssay data set | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 1.69 | nM | PubChem BioAssay data set | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 4.285 | nM | PubChem BioAssay data set | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 3.013 | nM | PubChem BioAssay data set | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 2.366 | nM | PubChem BioAssay data set | |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 7.907 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 55.98 | nM | PubChem BioAssay data set | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 1.919 | nM | PubChem BioAssay data set | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 9.727 | nM | PubChem BioAssay data set | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 6.053 | nM | PubChem BioAssay data set | |
NPT378 | Cell Line | NCI/ADR-RES | Homo sapiens | GI50 | 30.55 | nM | PubChem BioAssay data set | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 9.908 | nM | PubChem BioAssay data set | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 10.91 | nM | PubChem BioAssay data set | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 7.762 | nM | PubChem BioAssay data set | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 267.3 | nM | PubChem BioAssay data set | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 14.55 | nM | PubChem BioAssay data set | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 1.622 | nM | PubChem BioAssay data set | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 2.992 | nM | PubChem BioAssay data set | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 10.4 | nM | PubChem BioAssay data set | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 2.944 | nM | PubChem BioAssay data set | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 3.266 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 9.727 | nM | PubChem BioAssay data set | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 5.546 | nM | PubChem BioAssay data set | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 20.65 | nM | PubChem BioAssay data set | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 1.914 | nM | PubChem BioAssay data set | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 58.34 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 19.68 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 3.532 | nM | PubChem BioAssay data set | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 9.354 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 2.891 | nM | PubChem BioAssay data set | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 17.58 | nM | PubChem BioAssay data set | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 3.162 | nM | PubChem BioAssay data set | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 8.492 | nM | PubChem BioAssay data set | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 2.924 | nM | PubChem BioAssay data set | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 20.32 | nM | PubChem BioAssay data set | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 5.754 | nM | PubChem BioAssay data set | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 8.356 | nM | PubChem BioAssay data set | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 2.188 | nM | PubChem BioAssay data set | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 2.704 | nM | PubChem BioAssay data set | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 6.761 | nM | PubChem BioAssay data set | |
NPT400 | Cell Line | MDA-MB-435 | Homo sapiens | GI50 | 3.597 | nM | PubChem BioAssay data set | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 29.24 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | < | 260 | nM | PubChem BioAssay data set | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 4.498 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 6.124 | nM | PubChem BioAssay data set | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 8.75 | nM | PubChem BioAssay data set | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 18.37 | nM | PubChem BioAssay data set | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 9.528 | nM | PubChem BioAssay data set | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 3.664 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | AC50 | = | 889 | nM | PubChem BioAssay data set | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 11.27 | nM | PubChem BioAssay data set | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 2.244 | nM | PubChem BioAssay data set | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 6.887 | nM | PubChem BioAssay data set | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 20.56 | nM | PubChem BioAssay data set | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 6.471 | nM | PubChem BioAssay data set | |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 7307.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 100000 | nM | PubChem BioAssay data set | ||
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | 3662.6 | nM | PubChem BioAssay data set | |
NPT478 | Individual Protein | Ataxin-2 | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT1043 | Individual Protein | Glycoprotein hormones alpha chain | Homo sapiens | Potency | 2511.9 | nM | PubChem BioAssay data set | |
NPT3821 | Organism | Alternaria citri | Alternaria citri | MIC | > | 200 | ug/ml | 10775404 |
NPT3821 | Organism | Alternaria citri | Alternaria citri | EC90 | > | 200 | ug/ml | 10775404 |
NPT3660 | Organism | Fusarium avenaceum | Fusarium avenaceum | MIC | = | 200 | ug/ml | 10775404 |
NPT3660 | Organism | Fusarium avenaceum | Fusarium avenaceum | EC90 | = | 66 | ug/ml | 10775404 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | MIC | = | 25 | ug/ml | 10775404 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | EC90 | = | 35 | ug/ml | 10775404 |
NPT3821 | Organism | Alternaria citri | Alternaria citri | EC50 | > | 200 | ug/ml | 10775404 |
NPT3660 | Organism | Fusarium avenaceum | Fusarium avenaceum | EC50 | = | 8 | ug/ml | 10775404 |
NPT1198 | Organism | Magnaporthe grisea | Magnaporthe grisea | EC50 | = | 0.9 | ug/ml | 10775404 |
NPT721 | Individual Protein | Nuclear factor NF-kappa-B p65 subunit | Homo sapiens | ED50 | = | 0.08 | nM | 23301897 |
NPT2 | Others | Unspecified | ED50 | > | 0.05 | nM | 23301897 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | ED50 | = | 0.005 | nM | 23301897 |
NPT2 | Others | Unspecified | Potency | 9.2 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 163.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 7.3 | nM | PubChem BioAssay data set | ||
NPT861 | Individual Protein | Isocitrate dehydrogenase [NADP] cytoplasmic | Homo sapiens | Potency | 6.5 | nM | PubChem BioAssay data set | |
NPT160 | Individual Protein | TAR DNA-binding protein 43 | Homo sapiens | Potency | 31622.8 | nM | PubChem BioAssay data set | |
NPT920 | Individual Protein | Alpha-synuclein | Homo sapiens | Potency | 10000 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 0.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 58 | nM | PubChem BioAssay data set | ||
NPT152 | Individual Protein | Nuclear factor erythroid 2-related factor 2 | Homo sapiens | Potency | 14.6 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 6309.6 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | IC50 | = | 3900 | nM | 26863083 | |
NPT2 | Others | Unspecified | IC50 | = | 2600 | nM | 26863083 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC206061 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.948 | High Similarity | NPC308709 |
0.9111 | High Similarity | NPC235698 |
0.8962 | High Similarity | NPC79130 |
0.8956 | High Similarity | NPC169605 |
0.8859 | High Similarity | NPC258128 |
0.8763 | High Similarity | NPC293347 |
0.875 | High Similarity | NPC73422 |
0.875 | High Similarity | NPC310399 |
0.869 | High Similarity | NPC329743 |
0.869 | High Similarity | NPC209473 |
0.8588 | High Similarity | NPC90336 |
0.8305 | Intermediate Similarity | NPC254071 |
0.8305 | Intermediate Similarity | NPC271755 |
0.8305 | Intermediate Similarity | NPC149502 |
0.8305 | Intermediate Similarity | NPC222665 |
0.8284 | Intermediate Similarity | NPC87363 |
0.8283 | Intermediate Similarity | NPC475349 |
0.8283 | Intermediate Similarity | NPC475292 |
0.8283 | Intermediate Similarity | NPC475565 |
0.8283 | Intermediate Similarity | NPC475442 |
0.8232 | Intermediate Similarity | NPC184607 |
0.8171 | Intermediate Similarity | NPC470937 |
0.8167 | Intermediate Similarity | NPC23593 |
0.815 | Intermediate Similarity | NPC475624 |
0.8144 | Intermediate Similarity | NPC20360 |
0.8118 | Intermediate Similarity | NPC51543 |
0.8111 | Intermediate Similarity | NPC107739 |
0.8077 | Intermediate Similarity | NPC236089 |
0.8066 | Intermediate Similarity | NPC263955 |
0.8022 | Intermediate Similarity | NPC29587 |
0.7949 | Intermediate Similarity | NPC14390 |
0.7949 | Intermediate Similarity | NPC197125 |
0.7871 | Intermediate Similarity | NPC470846 |
0.7853 | Intermediate Similarity | NPC470936 |
0.7765 | Intermediate Similarity | NPC212697 |
0.7735 | Intermediate Similarity | NPC129578 |
0.7654 | Intermediate Similarity | NPC92589 |
0.7637 | Intermediate Similarity | NPC476459 |
0.7627 | Intermediate Similarity | NPC189730 |
0.76 | Intermediate Similarity | NPC474772 |
0.76 | Intermediate Similarity | NPC472636 |
0.76 | Intermediate Similarity | NPC474744 |
0.76 | Intermediate Similarity | NPC472423 |
0.76 | Intermediate Similarity | NPC471675 |
0.7571 | Intermediate Similarity | NPC164152 |
0.7557 | Intermediate Similarity | NPC31627 |
0.7557 | Intermediate Similarity | NPC473996 |
0.7557 | Intermediate Similarity | NPC327269 |
0.7557 | Intermediate Similarity | NPC285623 |
0.7557 | Intermediate Similarity | NPC476238 |
0.7556 | Intermediate Similarity | NPC96031 |
0.7543 | Intermediate Similarity | NPC472421 |
0.7542 | Intermediate Similarity | NPC469479 |
0.7514 | Intermediate Similarity | NPC476244 |
0.7514 | Intermediate Similarity | NPC303950 |
0.75 | Intermediate Similarity | NPC471676 |
0.75 | Intermediate Similarity | NPC263384 |
0.75 | Intermediate Similarity | NPC28724 |
0.75 | Intermediate Similarity | NPC472580 |
0.75 | Intermediate Similarity | NPC471229 |
0.75 | Intermediate Similarity | NPC472420 |
0.75 | Intermediate Similarity | NPC470810 |
0.75 | Intermediate Similarity | NPC471677 |
0.75 | Intermediate Similarity | NPC472422 |
0.75 | Intermediate Similarity | NPC476335 |
0.75 | Intermediate Similarity | NPC244577 |
0.7486 | Intermediate Similarity | NPC277032 |
0.7486 | Intermediate Similarity | NPC475621 |
0.7486 | Intermediate Similarity | NPC476340 |
0.7474 | Intermediate Similarity | NPC83019 |
0.7474 | Intermediate Similarity | NPC469437 |
0.7473 | Intermediate Similarity | NPC471286 |
0.7473 | Intermediate Similarity | NPC309692 |
0.7473 | Intermediate Similarity | NPC214279 |
0.7471 | Intermediate Similarity | NPC14875 |
0.7459 | Intermediate Similarity | NPC74854 |
0.7459 | Intermediate Similarity | NPC30655 |
0.7459 | Intermediate Similarity | NPC45124 |
0.7459 | Intermediate Similarity | NPC186228 |
0.7458 | Intermediate Similarity | NPC477957 |
0.7458 | Intermediate Similarity | NPC210597 |
0.7458 | Intermediate Similarity | NPC473236 |
0.7458 | Intermediate Similarity | NPC217149 |
0.7458 | Intermediate Similarity | NPC475790 |
0.7458 | Intermediate Similarity | NPC216035 |
0.7457 | Intermediate Similarity | NPC311144 |
0.7446 | Intermediate Similarity | NPC88378 |
0.7446 | Intermediate Similarity | NPC211713 |
0.7444 | Intermediate Similarity | NPC40583 |
0.7443 | Intermediate Similarity | NPC267117 |
0.743 | Intermediate Similarity | NPC78554 |
0.743 | Intermediate Similarity | NPC474609 |
0.743 | Intermediate Similarity | NPC109967 |
0.743 | Intermediate Similarity | NPC164427 |
0.743 | Intermediate Similarity | NPC20530 |
0.743 | Intermediate Similarity | NPC208152 |
0.743 | Intermediate Similarity | NPC10754 |
0.743 | Intermediate Similarity | NPC474738 |
0.743 | Intermediate Similarity | NPC78492 |
0.743 | Intermediate Similarity | NPC129053 |
0.743 | Intermediate Similarity | NPC215917 |
0.743 | Intermediate Similarity | NPC469936 |
0.743 | Intermediate Similarity | NPC321372 |
0.743 | Intermediate Similarity | NPC165483 |
0.743 | Intermediate Similarity | NPC475797 |
0.7427 | Intermediate Similarity | NPC307287 |
0.7423 | Intermediate Similarity | NPC204580 |
0.7419 | Intermediate Similarity | NPC472584 |
0.7416 | Intermediate Similarity | NPC7989 |
0.7416 | Intermediate Similarity | NPC20907 |
0.7416 | Intermediate Similarity | NPC203080 |
0.7416 | Intermediate Similarity | NPC100134 |
0.7416 | Intermediate Similarity | NPC223701 |
0.7416 | Intermediate Similarity | NPC209760 |
0.7416 | Intermediate Similarity | NPC244250 |
0.7416 | Intermediate Similarity | NPC469405 |
0.7416 | Intermediate Similarity | NPC472583 |
0.7414 | Intermediate Similarity | NPC299011 |
0.7409 | Intermediate Similarity | NPC264938 |
0.7403 | Intermediate Similarity | NPC220582 |
0.7403 | Intermediate Similarity | NPC304839 |
0.7403 | Intermediate Similarity | NPC476337 |
0.7401 | Intermediate Similarity | NPC319910 |
0.7401 | Intermediate Similarity | NPC278476 |
0.7401 | Intermediate Similarity | NPC474023 |
0.7401 | Intermediate Similarity | NPC474021 |
0.7401 | Intermediate Similarity | NPC254412 |
0.7401 | Intermediate Similarity | NPC262039 |
0.7401 | Intermediate Similarity | NPC262038 |
0.7399 | Intermediate Similarity | NPC113770 |
0.7396 | Intermediate Similarity | NPC474687 |
0.7391 | Intermediate Similarity | NPC43065 |
0.7391 | Intermediate Similarity | NPC476277 |
0.7391 | Intermediate Similarity | NPC53640 |
0.7391 | Intermediate Similarity | NPC119589 |
0.7391 | Intermediate Similarity | NPC82330 |
0.7386 | Intermediate Similarity | NPC472628 |
0.7386 | Intermediate Similarity | NPC317492 |
0.7377 | Intermediate Similarity | NPC472581 |
0.7377 | Intermediate Similarity | NPC63438 |
0.7377 | Intermediate Similarity | NPC124038 |
0.7374 | Intermediate Similarity | NPC108937 |
0.7374 | Intermediate Similarity | NPC471116 |
0.7374 | Intermediate Similarity | NPC470681 |
0.7374 | Intermediate Similarity | NPC217706 |
0.7374 | Intermediate Similarity | NPC207809 |
0.7374 | Intermediate Similarity | NPC304207 |
0.7374 | Intermediate Similarity | NPC477530 |
0.7374 | Intermediate Similarity | NPC476169 |
0.7374 | Intermediate Similarity | NPC48579 |
0.7374 | Intermediate Similarity | NPC259710 |
0.7374 | Intermediate Similarity | NPC477958 |
0.7374 | Intermediate Similarity | NPC279218 |
0.7371 | Intermediate Similarity | NPC470646 |
0.7371 | Intermediate Similarity | NPC472918 |
0.7371 | Intermediate Similarity | NPC473133 |
0.7371 | Intermediate Similarity | NPC44721 |
0.7371 | Intermediate Similarity | NPC122828 |
0.7371 | Intermediate Similarity | NPC202494 |
0.7371 | Intermediate Similarity | NPC308200 |
0.7371 | Intermediate Similarity | NPC211466 |
0.7371 | Intermediate Similarity | NPC3779 |
0.7371 | Intermediate Similarity | NPC472627 |
0.7371 | Intermediate Similarity | NPC47388 |
0.7371 | Intermediate Similarity | NPC470670 |
0.7371 | Intermediate Similarity | NPC176869 |
0.7371 | Intermediate Similarity | NPC476182 |
0.7371 | Intermediate Similarity | NPC40086 |
0.7366 | Intermediate Similarity | NPC120220 |
0.7366 | Intermediate Similarity | NPC91043 |
0.7366 | Intermediate Similarity | NPC279209 |
0.7366 | Intermediate Similarity | NPC102277 |
0.7363 | Intermediate Similarity | NPC97812 |
0.736 | Intermediate Similarity | NPC243171 |
0.736 | Intermediate Similarity | NPC10807 |
0.736 | Intermediate Similarity | NPC161881 |
0.736 | Intermediate Similarity | NPC138288 |
0.736 | Intermediate Similarity | NPC150123 |
0.736 | Intermediate Similarity | NPC56232 |
0.736 | Intermediate Similarity | NPC35567 |
0.736 | Intermediate Similarity | NPC171651 |
0.736 | Intermediate Similarity | NPC244583 |
0.7356 | Intermediate Similarity | NPC303185 |
0.7356 | Intermediate Similarity | NPC124780 |
0.7356 | Intermediate Similarity | NPC87486 |
0.7356 | Intermediate Similarity | NPC184649 |
0.7353 | Intermediate Similarity | NPC475836 |
0.7349 | Intermediate Similarity | NPC162801 |
0.7345 | Intermediate Similarity | NPC476509 |
0.7345 | Intermediate Similarity | NPC476185 |
0.7345 | Intermediate Similarity | NPC321896 |
0.7345 | Intermediate Similarity | NPC105136 |
0.7345 | Intermediate Similarity | NPC471115 |
0.7345 | Intermediate Similarity | NPC29777 |
0.7337 | Intermediate Similarity | NPC3049 |
0.7337 | Intermediate Similarity | NPC300053 |
0.7333 | Intermediate Similarity | NPC198489 |
0.7333 | Intermediate Similarity | NPC61112 |
0.733 | Intermediate Similarity | NPC39195 |
0.733 | Intermediate Similarity | NPC145467 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC206061 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.7814 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7556 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7409 | Intermediate Similarity | NPD4363 | Phase 3 |
0.7409 | Intermediate Similarity | NPD4360 | Phase 2 |
0.7377 | Intermediate Similarity | NPD8051 | Clinical (unspecified phase) |
0.7377 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7371 | Intermediate Similarity | NPD4361 | Phase 2 |
0.7371 | Intermediate Similarity | NPD4362 | Clinical (unspecified phase) |
0.7286 | Intermediate Similarity | NPD7497 | Discontinued |
0.7263 | Intermediate Similarity | NPD7090 | Clinical (unspecified phase) |
0.7225 | Intermediate Similarity | NPD7466 | Approved |
0.7222 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.7207 | Intermediate Similarity | NPD7615 | Clinical (unspecified phase) |
0.7202 | Intermediate Similarity | NPD2238 | Phase 2 |
0.72 | Intermediate Similarity | NPD7213 | Phase 3 |
0.72 | Intermediate Similarity | NPD7212 | Phase 2 |
0.7186 | Intermediate Similarity | NPD2493 | Approved |
0.7186 | Intermediate Similarity | NPD2494 | Approved |
0.7182 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7167 | Intermediate Similarity | NPD1934 | Approved |
0.7164 | Intermediate Similarity | NPD4583 | Approved |
0.7164 | Intermediate Similarity | NPD4582 | Approved |
0.7159 | Intermediate Similarity | NPD7447 | Phase 1 |
0.7158 | Intermediate Similarity | NPD7549 | Discontinued |
0.7157 | Intermediate Similarity | NPD2973 | Approved |
0.7157 | Intermediate Similarity | NPD2974 | Approved |
0.7157 | Intermediate Similarity | NPD2975 | Approved |
0.7151 | Intermediate Similarity | NPD6003 | Clinical (unspecified phase) |
0.7151 | Intermediate Similarity | NPD6006 | Clinical (unspecified phase) |
0.7151 | Intermediate Similarity | NPD4380 | Phase 2 |
0.7151 | Intermediate Similarity | NPD6005 | Phase 3 |
0.7151 | Intermediate Similarity | NPD6002 | Phase 3 |
0.7151 | Intermediate Similarity | NPD6004 | Phase 3 |
0.7151 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.7151 | Intermediate Similarity | NPD6166 | Phase 2 |
0.7151 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD6667 | Approved |
0.7143 | Intermediate Similarity | NPD6666 | Approved |
0.7136 | Intermediate Similarity | NPD4580 | Approved |
0.7135 | Intermediate Similarity | NPD7033 | Discontinued |
0.7127 | Intermediate Similarity | NPD5761 | Phase 2 |
0.7127 | Intermediate Similarity | NPD5760 | Phase 2 |
0.7127 | Intermediate Similarity | NPD2393 | Clinical (unspecified phase) |
0.7114 | Intermediate Similarity | NPD4004 | Approved |
0.7114 | Intermediate Similarity | NPD4002 | Approved |
0.7104 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.71 | Intermediate Similarity | NPD3452 | Approved |
0.71 | Intermediate Similarity | NPD3450 | Approved |
0.7094 | Intermediate Similarity | NPD7584 | Approved |
0.7083 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.7077 | Intermediate Similarity | NPD3808 | Clinical (unspecified phase) |
0.7074 | Intermediate Similarity | NPD3818 | Discontinued |
0.7072 | Intermediate Similarity | NPD7577 | Discontinued |
0.7066 | Intermediate Similarity | NPD4908 | Phase 1 |
0.7062 | Intermediate Similarity | NPD7004 | Clinical (unspecified phase) |
0.7062 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.7059 | Intermediate Similarity | NPD4575 | Clinical (unspecified phase) |
0.7052 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.7052 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.7049 | Intermediate Similarity | NPD4965 | Approved |
0.7049 | Intermediate Similarity | NPD4966 | Approved |
0.7049 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7049 | Intermediate Similarity | NPD3882 | Suspended |
0.7049 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.7033 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.7033 | Intermediate Similarity | NPD2801 | Approved |
0.7027 | Intermediate Similarity | NPD5494 | Approved |
0.702 | Intermediate Similarity | NPD7667 | Clinical (unspecified phase) |
0.7011 | Intermediate Similarity | NPD7075 | Discontinued |
0.7011 | Intermediate Similarity | NPD1549 | Phase 2 |
0.6994 | Remote Similarity | NPD2796 | Approved |
0.699 | Remote Similarity | NPD2488 | Approved |
0.699 | Remote Similarity | NPD2490 | Approved |
0.6984 | Remote Similarity | NPD7177 | Discontinued |
0.6982 | Remote Similarity | NPD4907 | Clinical (unspecified phase) |
0.6978 | Remote Similarity | NPD37 | Approved |
0.6978 | Remote Similarity | NPD6801 | Discontinued |
0.6973 | Remote Similarity | NPD6234 | Discontinued |
0.6971 | Remote Similarity | NPD2654 | Approved |
0.6966 | Remote Similarity | NPD7410 | Clinical (unspecified phase) |
0.6959 | Remote Similarity | NPD6355 | Discontinued |
0.6952 | Remote Similarity | NPD7229 | Phase 3 |
0.6952 | Remote Similarity | NPD7315 | Approved |
0.6952 | Remote Similarity | NPD3787 | Discontinued |
0.6944 | Remote Similarity | NPD4210 | Discontinued |
0.694 | Remote Similarity | NPD6668 | Clinical (unspecified phase) |
0.6938 | Remote Similarity | NPD7930 | Approved |
0.6923 | Remote Similarity | NPD7411 | Suspended |
0.6923 | Remote Similarity | NPD6072 | Discontinued |
0.6919 | Remote Similarity | NPD4466 | Phase 1 |
0.6919 | Remote Similarity | NPD3749 | Approved |
0.6915 | Remote Similarity | NPD7237 | Clinical (unspecified phase) |
0.691 | Remote Similarity | NPD6799 | Approved |
0.6906 | Remote Similarity | NPD8158 | Clinical (unspecified phase) |
0.6897 | Remote Similarity | NPD5006 | Approved |
0.6897 | Remote Similarity | NPD5005 | Approved |
0.6897 | Remote Similarity | NPD6032 | Approved |
0.6895 | Remote Similarity | NPD7893 | Clinical (unspecified phase) |
0.6889 | Remote Similarity | NPD7427 | Discontinued |
0.6885 | Remote Similarity | NPD6844 | Discontinued |
0.6882 | Remote Similarity | NPD6315 | Phase 2 |
0.6882 | Remote Similarity | NPD6798 | Discontinued |
0.6872 | Remote Similarity | NPD7019 | Approved |
0.6872 | Remote Similarity | NPD7020 | Approved |
0.6869 | Remote Similarity | NPD7296 | Approved |
0.6868 | Remote Similarity | NPD6599 | Discontinued |
0.6862 | Remote Similarity | NPD3051 | Approved |
0.6859 | Remote Similarity | NPD7804 | Clinical (unspecified phase) |
0.6859 | Remote Similarity | NPD5844 | Phase 1 |
0.6856 | Remote Similarity | NPD2971 | Approved |
0.6856 | Remote Similarity | NPD2968 | Approved |
0.6845 | Remote Similarity | NPD2904 | Discontinued |
0.6845 | Remote Similarity | NPD6746 | Phase 2 |
0.6845 | Remote Similarity | NPD2042 | Clinical (unspecified phase) |
0.6845 | Remote Similarity | NPD5647 | Approved |
0.6845 | Remote Similarity | NPD7583 | Approved |
0.6845 | Remote Similarity | NPD2041 | Clinical (unspecified phase) |
0.6839 | Remote Similarity | NPD1510 | Phase 2 |
0.6839 | Remote Similarity | NPD6559 | Discontinued |
0.6837 | Remote Similarity | NPD4663 | Approved |
0.6837 | Remote Similarity | NPD3863 | Clinical (unspecified phase) |
0.6836 | Remote Similarity | NPD4628 | Phase 3 |
0.6825 | Remote Similarity | NPD2969 | Approved |
0.6825 | Remote Similarity | NPD5242 | Approved |
0.6825 | Remote Similarity | NPD2970 | Approved |
0.6823 | Remote Similarity | NPD7074 | Phase 3 |
0.6821 | Remote Similarity | NPD8053 | Approved |
0.6821 | Remote Similarity | NPD8054 | Approved |
0.6818 | Remote Similarity | NPD2424 | Discontinued |
0.6816 | Remote Similarity | NPD7837 | Clinical (unspecified phase) |
0.6816 | Remote Similarity | NPD1511 | Approved |
0.6812 | Remote Similarity | NPD7585 | Approved |
0.6811 | Remote Similarity | NPD3817 | Phase 2 |
0.6811 | Remote Similarity | NPD2560 | Approved |
0.6811 | Remote Similarity | NPD2563 | Approved |
0.6809 | Remote Similarity | NPD6959 | Discontinued |
0.6806 | Remote Similarity | NPD7228 | Approved |
0.6806 | Remote Similarity | NPD3751 | Discontinued |
0.6806 | Remote Similarity | NPD5940 | Clinical (unspecified phase) |
0.6806 | Remote Similarity | NPD6620 | Discovery |
0.6802 | Remote Similarity | NPD1612 | Clinical (unspecified phase) |
0.6802 | Remote Similarity | NPD1613 | Approved |
0.68 | Remote Similarity | NPD6100 | Approved |
0.68 | Remote Similarity | NPD4477 | Approved |
0.68 | Remote Similarity | NPD4476 | Approved |
0.68 | Remote Similarity | NPD6099 | Approved |
0.6798 | Remote Similarity | NPD7910 | Clinical (unspecified phase) |
0.6794 | Remote Similarity | NPD7783 | Phase 2 |
0.6794 | Remote Similarity | NPD7782 | Clinical (unspecified phase) |
0.6776 | Remote Similarity | NPD6502 | Phase 2 |
0.6774 | Remote Similarity | NPD7768 | Phase 2 |
0.6772 | Remote Similarity | NPD5710 | Approved |
0.6772 | Remote Similarity | NPD5711 | Approved |
0.6772 | Remote Similarity | NPD6232 | Discontinued |
0.6771 | Remote Similarity | NPD6020 | Phase 2 |
0.6771 | Remote Similarity | NPD7054 | Approved |
0.6771 | Remote Similarity | NPD6042 | Phase 2 |
0.6771 | Remote Similarity | NPD42 | Phase 2 |
0.6769 | Remote Similarity | NPD4578 | Approved |
0.6769 | Remote Similarity | NPD4577 | Approved |
0.6757 | Remote Similarity | NPD7819 | Suspended |
0.6757 | Remote Similarity | NPD7046 | Clinical (unspecified phase) |
0.6754 | Remote Similarity | NPD7473 | Discontinued |
0.6753 | Remote Similarity | NPD7039 | Approved |
0.6753 | Remote Similarity | NPD7685 | Pre-registration |
0.6753 | Remote Similarity | NPD7038 | Approved |
0.6749 | Remote Similarity | NPD7810 | Phase 3 |
0.6749 | Remote Similarity | NPD7811 | Phase 3 |
0.6747 | Remote Similarity | NPD1610 | Phase 2 |
0.6745 | Remote Similarity | NPD7047 | Phase 3 |
0.6744 | Remote Similarity | NPD6233 | Phase 2 |
0.674 | Remote Similarity | NPD1512 | Approved |
0.6736 | Remote Similarity | NPD7472 | Approved |
0.6731 | Remote Similarity | NPD7701 | Phase 2 |
0.6729 | Remote Similarity | NPD4665 | Approved |
0.6729 | Remote Similarity | NPD4111 | Phase 1 |
0.6724 | Remote Similarity | NPD6653 | Approved |
0.672 | Remote Similarity | NPD5402 | Approved |
0.6717 | Remote Similarity | NPD7906 | Approved |
0.6713 | Remote Similarity | NPD6997 | Phase 2 |
0.6706 | Remote Similarity | NPD2861 | Phase 2 |
0.6705 | Remote Similarity | NPD1240 | Approved |
0.6705 | Remote Similarity | NPD5712 | Approved |
0.6703 | Remote Similarity | NPD5403 | Approved |
0.6702 | Remote Similarity | NPD2489 | Approved |
0.6702 | Remote Similarity | NPD27 | Approved |
0.6702 | Remote Similarity | NPD7852 | Clinical (unspecified phase) |
0.6702 | Remote Similarity | NPD3451 | Clinical (unspecified phase) |
0.6702 | Remote Similarity | NPD8245 | Clinical (unspecified phase) |
0.6701 | Remote Similarity | NPD3823 | Discontinued |
0.6701 | Remote Similarity | NPD6797 | Phase 2 |
0.6701 | Remote Similarity | NPD7993 | Clinical (unspecified phase) |
0.6701 | Remote Similarity | NPD8055 | Clinical (unspecified phase) |
0.67 | Remote Similarity | NPD4420 | Approved |
0.6686 | Remote Similarity | NPD2200 | Suspended |
0.6685 | Remote Similarity | NPD4662 | Approved |
0.6685 | Remote Similarity | NPD2800 | Approved |
0.6685 | Remote Similarity | NPD4661 | Approved |
0.6685 | Remote Similarity | NPD7421 | Clinical (unspecified phase) |
0.6685 | Remote Similarity | NPD5177 | Phase 3 |
PubChem CID   | 331783 |
ChEMBL   | CHEMBL438139 |
ZINC   |
Molecular Weight:   | 505.21 |
ALogP:   | -2.5561 |
MLogP:   | 3.77 |
XLogP:   | 5.007 |
# Rotatable Bonds:   | 14 |
Polar Surface Area:   | 97.69 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 2 |
# Rings:   | 5 |
# Heavy Atoms:   | 37 |